2910 articles in this topic
A new health tech partnership merges diabetes management with cardiovascular monitoring to tackle cardiometabolic risk before complications arise.
Cerevance's solengepras targets GPR6 receptors to cut OFF periods in Parkinson's โ a first non-dopaminergic approach in decades.
Cyclarity's UDP-003 shows first human evidence of excreting oxidized cholesterol, pointing toward reversing arterial damage rather than just slowing it.
Dr Valter Longo argues the 5-day fasting-mimicking diet triggers deep cellular repair โ from autophagy peaks to tissue regeneration after refeeding.
The submitted press release could not be verified as a recent NIH publication. Content could not be summarized.
WashU Medicine's Long Life Family Study renewal uses long-read sequencing to decode why some families consistently escape age-related disease.
WashU Medicine's Long Life Family Study gets a major boost, using long-read sequencing to find why some families live exceptionally long lives.
A key m6A RNA modifier enables colorectal cancer cells to resist chemotherapy by stabilizing a transcription factor that regulates iron homeostasis.
ฮฑKG supplementation restores glutamine metabolism and halts cartilage destruction in OA models through H3K27me3 demethylation.
A landmark review reveals why aging immune systems lose the ability to clear senescent cells โ and how new therapies could restore this critical defense.
A landmark NIH-funded consortium is building the first reference atlas of somatic mutations across healthy human tissues to decode aging and disease.
A novel mass spectrometry method maps 482,000 protein-metabolite relationships, revealing how LRRC58 governs cysteine catabolism and hepatic cholesterol.
